Two of pharma’s most in-demand careers in one diploma
If you are a B.Pharm, M.Pharm, or life-sciences graduate who wants a serious, job-ready entry into the pharmaceutical industry in 2026, the PG Diploma in Pharmacovigilance & Regulatory Affairs (PGDPV) gives you two of the most reliable career doors at once — drug safety and regulatory affairs — in a single structured 6-month programme.
The logic is structural. Every drug sold anywhere must be monitored for safety throughout its lifecycle, and every drug must be approved and kept compliant by regulators for that entire commercial life. Pharmacovigilance has the fastest hiring cycles in clinical research, and regulatory affairs offers one of the steadiest long-term compensation curves in pharma. Learning both — rather than one in isolation — makes you measurably more employable, because in practice the two disciplines are the same conversation: safety data drives label changes, risk management plans feed submissions, and PSURs are filed to authorities on regulatory timelines.
Pune is the right place to do this. The Hinjewadi-Wakad-Bhosari corridor houses PV and regulatory operations for pharma sponsors Cipla, Sun Pharma, Lupin, Glenmark, and Emcure, alongside CROs including Syngene, Veeda Clinical Research, Lambda Therapeutic Research, IQVIA, ICON, and Parexel — and all of them hire trained drug-safety and regulatory talent continuously.
What you will learn
The course is built around what employers actually test in interviews and expect on day one, not academic theory.
Pharmacovigilance operations. You build a working command of the ICSR lifecycle — intake, triage, MedDRA coding, narrative writing, causality assessment, and E2B(R3) electronic submission within 7- and 15-day timelines — the core of every entry-level drug-safety role.
Safety databases and analytics. You get hands-on with four safety platforms — Oracle Argus, ARISg and ABcube, plus an overview of Veeva Vault Safety — and progress into signal detection, aggregate reporting (PSUR, PBRER, DSUR), risk management plans, and GVP.
The regulatory framework. You gain real depth in CDSCO and the New Drugs and Clinical Trials Rules 2019, plus USFDA (21 CFR, IND/NDA/ANDA/BLA) and EMA procedures, so you can speak confidently about how drugs are approved and governed across markets.
Submissions and lifecycle compliance. You learn CTD/eCTD structure, sequence numbering and validation, DMF and dossier compilation, labelling, and post-marketing compliance — including the PV–regulatory interface where the two disciplines meet.
How the course is structured
PGDPV runs over six months in both offline (classroom) and online batches, so you can attend in person at our Wakad campus or join live from anywhere in India. Weekday-evening and weekend batches are available for working professionals.
The first phase builds pharmacovigilance foundations — terminology, the ICSR lifecycle, and MedDRA coding — followed by extended hands-on processing in Argus, ARISg and ABcube and progression into signal detection and aggregate reporting. The middle phase moves into the regulatory framework: CDSCO, USFDA, and EMA, then CTD/eCTD dossier compilation and DMF work. The final phase covers labelling, post-marketing compliance, inspection readiness, and intensive placement preparation. Faculty are practising PV and regulatory professionals from Pune’s pharma corridor — not full-time academics — so you learn from people who close cases and file submissions every day.
Placement infrastructure
We treat placement as a deliverable, not an afterthought. Every student completes structured placement preparation: PV- and regulatory-specific resume calibration, multiple rounds of mock interviews with hiring managers from partner companies, and direct introductions to our 50+ CRO and pharma partners across Pune. Because the diploma qualifies you for both drug-safety and regulatory roles, you apply into two hiring pipelines rather than one. Starting CTCs typically range from ₹3.6 to ₹4.8 LPA depending on the role and your degree, with clear progression to senior PV, signal management, and regulatory roles — and ₹16–28 LPA at manager level.
Who this course is right for
You will get the most out of PGDPV if you are:
- A fresh graduate (B.Pharm, M.Pharm preferred; B.Sc, M.Sc in life sciences, microbiology, biotechnology, chemistry; BDS, BAMS, BHMS) who wants a job-ready entry into pharma
- A working professional in an adjacent field who wants to add both drug-safety and regulatory skills to your profile
- Someone who wants two entry doors, not one — the flexibility to start in PV and move into regulatory affairs, or vice versa
- A career-switcher from healthcare or life sciences seeking a process-driven, office-based pharma role with strong progression
Apply for the next batch
Batches start every quarter at our Wakad, Pune campus, with limited seats per batch to protect hands-on platform access and faculty attention. Early applicants get priority for placement preparation and corporate partner introductions. EMI options are available across the programme.
Reach out via WhatsApp for an immediate conversation about your background and the right intake batch for you.
Related courses
If you want a shorter entry point or an adjacent specialisation, the natural next steps are:
- Certificate in Pharmacovigilance & Regulatory Affairs — the shorter, focused entry credential covering the same two disciplines
- Certificate in Medical Writing — a closely related discipline; CSR, protocol, and narrative writing overlap heavily with PV and regulatory work
- PG Diploma in Clinical Research — the broader 6-month credential across the whole clinical research field
- Certificate in Clinical Research — a fast, affordable foundation if you are still choosing a specialisation
Further reading
- Clinical Research After B.Pharm — all the entry paths compared
- Pharmacovigilance Career Guide 2026 — salary by level, top Pune employers, and how to get started
- Career Roadmap — how to plan your first three years